Department of Medicine 5 – Haematology and Oncology

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients (2025) Dingfelder J, Taubmann J, von Heydebrand F, Aigner M, Bergmann C, Knitza J, Park S, et al. Journal article Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. (2025) Unglaub JM, Schlenk RF, Middeke JM, Krause S, Kraus S, Einsele H, Kramer M, et al. Journal article Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland (2025) Denk A, Fante MA, Heidenreich S, Greinix HT, Drouet EMW, Egger-Heidrich K, Marx J, et al. Journal article Morphology-dependent entry kinetics and spread of influenza A virus (2025) Peterl S, Lahr CM, Schneider CN, Meyer J, Podlipensky X, Lechner V, Villiou M, et al. Journal article Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma (2025) Müller F, Schwingen NR, Hagen M, Scholz J, Aigner M, Wirsching A, Taubmann J, et al. Journal article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience (2024) Innocenti I, Mosca A, Tomasso A, Galitzia A, Scarfò L, Morelli F, Galli E, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article Oligoclonal CD4+CXCR5+ T cells with a cytotoxic phenotype appear in tonsils and blood (2024) Liang C, Spörl S, Xiao Y, Habenicht KM, Haeusl SS, Sandner I, Winkler J, et al. Journal article